TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $45
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $35 to $45.
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $35 to $45.
